Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1092 of 5804
-
New injection plus radiation shows promise against cervical cancer
Disease control Recruiting nowThis is a seamless Phase 1/2 study consisting of two components. Phase 1 component is a dose-escalation, single arm, open label study in 10 patients to evaluate the safety and tolerability of KRC 01. Phase 2 component is a randomized, open label, controlled, multi-center study in…
Phase: PHASE1 • Sponsor: Kortuc, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Brain stimulation gets personal: new hope for chronic pain sufferers
Symptom relief Recruiting nowPrevious research has demonstrated that repetitive magnetic brain stimulation can be an effective adjunctive treatment for several conditions, including chronic pain. However, current stimulation protocols are typically standardized and do not account for individual variability i…
Phase: NA • Sponsor: Aalborg University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
New therapy aims to ease trauma in ovarian cancer patients
Symptom relief Not yet recruitingThe goal of this clinical trial is to investigate if CALM-TF (Trauma-Focused Managing Cancer and Living Meaningfully) is effective in treating traumatic stress symptoms in women with advanced ovarian cancer. It will also learn whether the efficacy differs at new diagnosis versus …
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New hope for tough cancers: experimental drug TB511 enters human trials
Disease control Not yet recruiting1. Study population \[TB511 Monotherapy Cohort for Phase 1 and Phase 2a Clinical Trial\] Patients with advanced solid tumors who are either refractory or intolerant to standard of care (SoC). \[Immune checkpoint inhibitors (ICIs) Combination Therapy Cohort for Phase 2a Cl…
Phase: PHASE1, PHASE2 • Sponsor: Twinpig Biolab, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
HPV pill trial aims to clear precancerous cells without surgery
Disease control Recruiting nowThe goal of this clinical trial is to investigate the safety and efficacy of Papillex® on the regression of abnormal cervical cells caused by HPV in women with a cervical intraepithelial neoplasia (CIN) 1 or 2 diagnosis. The main question it aims to answer is: Is there a differe…
Phase: NA • Sponsor: Papillex Inc. • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Cockroach extract may shield cancer patients from radiation burns
Prevention Recruiting nowTo evaluate the efficacy and safety of topical Periplaneta americana-derived Meilian Fuxin Solution for the prevention of radiation dermatitis in patients undergoing radiotherapy.
Phase: PHASE2, PHASE3 • Sponsor: West China Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:00 UTC
-
Brain training offers hope for epilepsy patients who Don't respond to drugs
Disease control Not yet recruitingA large proportion of patients (approximately 30%) with drug-resistant epilepsy are not eligible for surgical treatment. The alternatives that can be offered to reduce the frequency of seizures are neuromodulation (vagus nerve stimulation (VNS), deep brain stimulation (DBS), or t…
Phase: NA • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Could stem cells help tiniest babies breathe easier?
Disease control Not yet recruitingThe goal of this clinical trial is to evaluate the safety and potential efficacy of PNEUMOSTEM® for improving respiratory outcomes in very premature infants diagnosed with Early Pulmonary Arterial Hypertension. The main questions it aims to answer are: * In very premature infant…
Phase: PHASE1 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
New nanoparticle drug aims to fight tough lung cancer
Disease control Recruiting nowThe purpose of the Phase 1 research is to test the safety, tolerability, maximum tolerated dose, and pharmacokinetics (PK- the study of how a medicine moves through subject body. It looks at how the drug is absorbed, travels in your blood, reaches different parts of subject body,…
Phase: PHASE1, PHASE2 • Sponsor: SN BioScience • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Fasting-Mimicking diet tested to protect aging brains
Disease control Not yet recruitingThe study aims to evaluate the safety, feasibility, and preliminary efficacy of six-month fasting-mimicking (FMD) relative to Dietary Guidance intervention in middle-aged adults at elevated risk for Alzheimer's disease due to the apolipoprotein (APOE) ε4 allele. Participants rand…
Phase: NA • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New camera trick could slash stomach surgery risks
Symptom relief Not yet recruitingGastric cancer remains a major global health burden, ranking fifth in incidence worldwide and disproportionately affecting Asia, with China accounting for a significant share of cases and deaths. Early detection and minimally invasive treatment are critical to improving outcomes.…
Phase: NA • Sponsor: Xijing Hospital of Digestive Diseases • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New incision technique may ease Crohn's bowel blockages
Symptom relief Not yet recruitingThis study is designed as a controlled trial to evaluate the efficacy of balloon-assisted enteroscopy-guided radial incision therapy for the treatment of stricturing small bowel Crohn's disease. The study aims to compare therapeutic outcomes, procedure-related complications, and …
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
New drug cocktail aims to tackle Hard-to-Treat colorectal cancer
Disease control Recruiting nowIn this single-center,open-label, randomized, phase II study, the efficacy and feasibility of GSL synthetase inhibitor in combination with immune checkpoint inhibitor and/or regorafenib therapeutic regimen will be evaluated in patients with advanced/metastatic proficient mismatch…
Phase: PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New study aims to cut opioid prescriptions after prostate surgery
Symptom relief Recruiting nowThis prospective, interventional, open-label, phase 3 randomized study evaluates a multimodal analgesia discharge pathway to reduce automatic opioid prescribing following routine robotic-assisted laparoscopic prostatectomy (RALP). Patients are counseled on post-operative pain man…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
New monitoring method may help chest trauma patients breathe easier and leave the ventilator sooner
Disease control Not yet recruitingIn our previous study, the investigators analyzed more than 30,000 cases from the National Trauma Center Database and found that 66.4% of patients with severe blunt chest trauma had concurrent rib fractures, 55.87% had multiple fractures (≥4 ribs), and 37.4% had combined pulmonar…
Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New imaging agent could sharpen lung nodule diagnosis
Diagnosis Not yet recruitingThe excellent tumor-targeting efficacy of FAP has been confirmed by multiple clinical studies. The results unequivocally establish FAPI as a tumor-targeting ligand with significant potential, demonstrating important application prospects in translational oncology. However, its th…
Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
Brain tumor study aims to clear up scans by shifting chemo timing
Knowledge-focused Not yet recruitingBetter treatments are needed for high-grade gliomas (HGG), and new ways of treating this disease should be tested. The investigators want to see if giving medicine before radiation works well. After radiation, MRI scans can be harder to understand because radiation changes how th…
Phase: PHASE2 • Sponsor: The Cooper Health System • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
New drug MTM-H-001 takes on tough blood cancers
Disease control Not yet recruitingThis is an investigator-initiated, open-label, single-arm, dose-escalation and dose-expansion study to evaluate the safety, tolerability, PK, PD, and preliminary efficacy of MTM-H-001 in adult participants with relapsed/refractory (R/R) B-cell malignancies.
Phase: NA • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Heart attack drug may fix 'Hidden' vessel damage
Disease control Not yet recruitingDespite the success of restoration of epicardial blood flow by the primary percutaneous coronary intervention (PPCI), approximately one half of patients with ST-segment elevation myocardial infarction (STEMI) have failed myocardial reperfusion, namely microvascular dysfunction. P…
Phase: PHASE4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New orthosis aims to stop shoulder dislocation in stroke survivors
Prevention OngoingStroke is a leading cause of long-term disability worldwide. During the early stage of recovery after cerebral infarction, reduced muscle tone and muscle weakness in the affected upper limb may lead to shoulder instability and shoulder subluxation, which can subsequently result i…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC